Aim: To investigate the prevalence of pulmonary arterial hypertension (PAH) and the possible contributing factors for PAH in patients receiving regular continuous ambulatory peritoneal dialysis (CAPD)
Purpose: Pulmonary hypertension (PH) is a frequent and serious cardiovascular complication in patie...
AbstractIntroductionPulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pr...
Pulmonary hypertension (PH) is a recently recognized complication of chronic kidney disease (CKD), e...
Aim: To investigate the prevalence of pulmonary arterial hypertension (PAH) and the possible contrib...
¤ Aim: To investigate the prevalence of pulmonary arterial hypertension (PAH) and the possible contr...
Pulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pressure above 35 mm H...
AbstractObjectivesTo compare the prevalence of unexplained pulmonary artery hypertension (PAH) in he...
AbstractIntroductionPulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pr...
Introduction. Pulmonary hypertension (PHT) is an independent predictor of mortality. The aim of thi...
AbstractBackgroundPulmonary arterial hypertension is a newly recognized disease in patients with ren...
Introduction. Pulmonary hypertension (PHT) is an independent predictor of mortality. The aim of this...
recent dialysis patient survival rates are 62.7 % at 2 years and 29.3 % at 5 years. Although surviva...
IntroductionPulmonary hypertension (PH) is one of the most important accompanying comorbidities with...
Objectives: To compare the prevalence of unexplained pulmonary artery hypertension (PAH) in hemodial...
Pulmonary hypertension (PH) is common in patients with dialysis-dependent chronic kidney disease and...
Purpose: Pulmonary hypertension (PH) is a frequent and serious cardiovascular complication in patie...
AbstractIntroductionPulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pr...
Pulmonary hypertension (PH) is a recently recognized complication of chronic kidney disease (CKD), e...
Aim: To investigate the prevalence of pulmonary arterial hypertension (PAH) and the possible contrib...
¤ Aim: To investigate the prevalence of pulmonary arterial hypertension (PAH) and the possible contr...
Pulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pressure above 35 mm H...
AbstractObjectivesTo compare the prevalence of unexplained pulmonary artery hypertension (PAH) in he...
AbstractIntroductionPulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pr...
Introduction. Pulmonary hypertension (PHT) is an independent predictor of mortality. The aim of thi...
AbstractBackgroundPulmonary arterial hypertension is a newly recognized disease in patients with ren...
Introduction. Pulmonary hypertension (PHT) is an independent predictor of mortality. The aim of this...
recent dialysis patient survival rates are 62.7 % at 2 years and 29.3 % at 5 years. Although surviva...
IntroductionPulmonary hypertension (PH) is one of the most important accompanying comorbidities with...
Objectives: To compare the prevalence of unexplained pulmonary artery hypertension (PAH) in hemodial...
Pulmonary hypertension (PH) is common in patients with dialysis-dependent chronic kidney disease and...
Purpose: Pulmonary hypertension (PH) is a frequent and serious cardiovascular complication in patie...
AbstractIntroductionPulmonary arterial hypertension (PAH), defined as a systolic pulmonary artery pr...
Pulmonary hypertension (PH) is a recently recognized complication of chronic kidney disease (CKD), e...